related documents
- Discovery and characterization of new antigens for therapeutic vaccination against breast cancer Conferences
- Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin®) induces high response rates and durable remissions in patients with relapsed or refractory B-cell non hodgkin's lymphoma (NHL) Conferences